Losartan vs. Benicar hct: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Losartan and Benicar hct. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 231,510 people who take Losartan and Benicar hct, and is updated regularly.
What is Losartan?
Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,692 Losartan users. Check the latest studies of Losartan.
What is Benicar hct?
Benicar hct has active ingredients of hydrochlorothiazide; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 10,919 Benicar hct users. Check the latest studies of Benicar hct.
231,510 people who take Losartan and Benicar hct are studied.
Drugs being compared in this study:
- Losartan (losartan potassium)
- Benicar Hct (hydrochlorothiazide; olmesartan medoxomil)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Losartan:
- not at all: 1.97 %
- somewhat: 15.21 %
- moderate: 38.27 %
- high: 33.77 %
- very high: 10.77 %
Benicar Hct:
- not at all: 1.3 %
- somewhat: 11.93 %
- moderate: 28.2 %
- high: 41.21 %
- very high: 17.35 %
Want to compare Losartan with Benicar hct?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Losartan (170,800 reports)
- Benicar hct (10,270 reports)
Browse all side effects of Losartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Benicar hct:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on losartan potassium and hydrochlorothiazide; olmesartan medoxomil (the active ingredients of Losartan and Benicar hct, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gemcitabine and Breast Cancer for Women aged 60+ - 17 seconds ago
- Gemcitabine and Carcinoma - Ductal for Women aged 60+ - 18 seconds ago
- Gemcitabine and Cancer - Breast for Women aged 60+ - 18 seconds ago
- Gemcitabine and Carcinoma - Lobular for Women aged 60+ - 18 seconds ago
- Talwin Nx vs. Lyrica, side effect and effectiveness comparison - 34 seconds ago
- Etodolac and White Blood Cell Count Decreased for Women aged 60+ - 35 seconds ago
- Humalog and Urinary Incontinence for Women aged 50-59 - 40 seconds ago
- Humalog and Bladder Incontinence for Women aged 50-59 - 40 seconds ago
- Humalog and Urination - Uncontrollable for Women aged 50-59 - 41 seconds ago
- Humalog and Uncontrollable Urination for Women aged 50-59 - 41 seconds ago